beta

NVRO

Nevro Corp

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.

Market Cap: 529 Million

Primary Exchange: NEW YORK STOCK EXCHANGE INC.

Website: https://www.nevro.com

Shares Outstanding: 36.4 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.2788708709558887

Sector: Manufacturing

Industry: Surgical and Medical Instrument Manufacturing

Ethical Flags

Longest drawdown: 1028 trading days

From: 2020-12-23 To: 2024-03-07

Lowest Point:

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update

via: SeekingAlpha at 2019-06-12 01:06:09:000

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update

via: SeekingAlpha at 2019-06-12 01:06:09:000

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...

Nevro to Present at BMO 2019 Prescriptions for Success Healthcare Conference

via: PR Newswire at 2019-06-11 12:30:00:000

REDWOOD CITY, Calif. , June 11, 2019 /PRNewswire/ --Nevro Corp.(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the BMO 2019 Prescription… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud